97 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Disease in HIV-AIDS ... complex (MAC) disease ... #Prophylaxis #Opportunistic ... IDSA #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Disease in HIV-AIDS ... complex (MAC) disease ... #Prophylaxis #Opportunistic ... IDSA #management #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
known to have HIV ... diagnosed with HIV ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
hepatitis C virus (HCV ... DAAs #Antivirals #table ... #treatment #hcv ... HepatitisC #Management #Pharmacology
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
CNS Opportunistic ... present in 15% of cases ... Antimicrobial treatment ... Demyelinating disease ... caused by the JC
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... duration same as for treatment ... Note: Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
stepdown from IV ... conversion of IV ... #pharmacology #antibiotics ... #medications #table ... #treatment #drugs
Acute Retroviral Syndrome
Acute Retroviral Syndrome is the symptomatic presentation of acute human immunodeficiency virus infection

 •
Presentations: • Opportunistic ... 14%), in which case ... opportunistic infections ... antibody test) Treatment ... disease progression
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... mucoadhesive buccal tablet ... chew, or crush tablet ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... caution in pulmonary disease ... Treat underlying cause ... Treat underlying cause ... #Tachycardia #Treatment